GPR135 activators participate in a complex interplay of intracellular signaling events that ultimately enhance this G-protein coupled receptor's functionality. For instance, certain activators work by directly stimulating adenylyl cyclase, heightening intracellular cyclic AMP (cAMP) levels, a pivotal second messenger involved in GPCR signaling. The increased cAMP in turn can modulate the receptor's activity, as the receptor is intricately linked to pathways governed by cAMP. Other activators achieve a similar outcome by targeting different components of the signaling cascade; they may inhibit phosphodiesterases, leading to sustained cAMP levels, thereby influencing GPR135's activity. Additionally, activators may engage with various GPCRs that mediate the production of cAMP, which is likely to have a subsequent effect on GPR135's signaling pathways.
Moreover, the activation landscape for GPR135 extends to interactions with numerous other molecules that influence GPCR-related pathways. For instance, certain amino acids serve as substrates for enzymes that produce signaling molecules, such as nitric oxide, which is known to modulate GPCR signaling, hence potentially affecting GPR135. Furthermore, endogenous compounds that bind to their respective GPCRs can alter intracellular signaling cascades, thus potentially affecting GPR135 activation. Some activators may also trigger ion channel-linked receptors, leading to calcium influx and affecting downstream GPCR-mediated signaling pathways, which could indirectly influence GPR135 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A non-selective beta-adrenergic agonist that increases cAMP via GPCR signaling, thereby potentially enhancing GPR135 function. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibits phosphodiesterases, causing an increase in cAMP levels which could lead to the activation of GPR135 through cAMP-dependent pathways. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Binds to its GPCR leading to an increase in cAMP, which might have a subsequent effect on GPR135 signaling cascades. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, raises intracellular cAMP, potentially enhancing GPR135 activity linked to cAMP pathways. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Interacts with purinergic GPCRs to regulate adenylate cyclase and cAMP levels, which may in turn influence GPR135 activity. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
As a substrate for nitric oxide synthase, it engenders nitric oxide production, which can modulate GPCR signaling and potentially GPR135. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Through its action on histamine GPCRs, it can alter intracellular signaling cascades, possibly affecting GPR135 activation. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Activates vanilloid receptors leading to calcium influx, affecting GPCR-mediated signaling pathways and potentially GPR135 activity. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Binds to its GPCRs, leading to various downstream effects including potential cAMP modulation and indirect activation of GPR135. | ||||||